DE-DLBCL has demonstrated distinctive clinical features such as older age, advanced Ann Arbor stage, higher lactate dehydrogenase (LDH) level, higher Ki67 proliferation index, and higher international prognostic index (11–13). Here, MKI67 is linked to diffuse large B-cell lymphoma.